Cellectis (CLLS) Cash & Equivalents (2016 - 2023)
Historic Cash & Equivalents for Cellectis (CLLS) over the last 11 years, with Q3 2023 value amounting to $67.4 million.
- Cellectis' Cash & Equivalents fell 3101.96% to $67.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $67.4 million, marking a year-over-year decrease of 3101.96%. This contributed to the annual value of $93.2 million for FY2022, which is 4978.56% down from last year.
- Cellectis' Cash & Equivalents amounted to $67.4 million in Q3 2023, which was down 3101.96% from $93.2 million recorded in Q2 2023.
- In the past 5 years, Cellectis' Cash & Equivalents registered a high of $451.5 million during Q2 2019, and its lowest value of $67.4 million during Q3 2023.
- In the last 5 years, Cellectis' Cash & Equivalents had a median value of $241.1 million in 2020 and averaged $236.3 million.
- In the last 5 years, Cellectis' Cash & Equivalents soared by 6438.76% in 2019 and then crashed by 5365.74% in 2022.
- Over the past 5 years, Cellectis' Cash & Equivalents (Quarter) stood at $340.5 million in 2019, then decreased by 29.18% to $241.1 million in 2020, then decreased by 23.02% to $185.6 million in 2021, then tumbled by 49.79% to $93.2 million in 2022, then fell by 27.74% to $67.4 million in 2023.
- Its Cash & Equivalents stands at $67.4 million for Q3 2023, versus $93.2 million for Q2 2023 and $93.2 million for Q1 2023.